Multiple Rising Oral Doses of BI 201335 NA for Hepatitis
ID Number 07-0859
Principal Investigator(s)Douglas Dieterich
Department(s) or Division(s)
Liver Diseases
Description
The study is designed to find out if the new drug is effective, safe, and to determine the level of the drug in the patient's body (pharmacokinetics).
Contact Information
Douglas Dieterich, MD
douglas.dieterich@mountsinai.org
Recruiting Patients: No